Determination of TGF-β levels in the plasma samples isolated from healthy subjects and individuals with T2DM showed that decreased expression of GCLC correlated with significant increase in the levels of TGF-β in plasma samples from individuals with T2DM (Fig. 2C). This evidence concerns the gene GCLC and type 2 diabetes mellitus.